09:41 AM EST - Intellipharmaceutics International Inc. : Announced today that its financial statements for the interim period ended May 31, 2022 and related management's discussion and analysis and accompanying Chief Executive Officer and Chief Financial Officer certificates due July 15, will not be filed by the Filing Deadline.
Intellipharmaceutics International Inc.
shares T.IPCI are trading unchanged at $0.12.
